Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Lens

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Gastroenterology|February 21, 2023
Bepirovirsen-A New Therapy for Chronic Hepatitis B InfectionSabela Lens
Gastroenterology|April 25, 2025
Simvastatin and Rifaximin for Decompensated Cirrhosis: A Hope UnfulfilledSabela Lens
Gastroenterology|November 5, 2023
Successful HCV Viral Cure Is Not the End of the StorySabela Lens
Gastroenterology|October 16, 2022
An Epidemic of Acute Hepatitis of Unknown Etiology in ChildrenSabela Lens
Gastroenterology|May 13, 2023
Bulevirtide for Chronic Hepatitis DeltaSabela Lens
Gastroenterology|June 27, 2024
Resmetirom for Non-alcoholic SteatohepatitisSabela Lens
Gastroenterology|February 22, 2024
In Search of the Best Second-Line Therapy for Primary Biliary CholangitisSabela Lens
Gastroenterology|July 25, 2025
Semaglutide in MASH: A Promising Step Forward With Room for ImprovementSabela Lens
The Lancet. Gastroenterology & Hepatology|July 13, 2023
More is not always better for novel hepatitis B therapiesSabela Lens, Xavier Forns
Atencion Primaria|October 5, 2015
[Cost-efficacy of new antiviral treatments for chronic hepatitis C]Sabela Lens, Martín Bonacci
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Gastroenterology|February 21, 2023
Bepirovirsen-A New Therapy for Chronic Hepatitis B InfectionSabela Lens
Gastroenterology|April 25, 2025
Simvastatin and Rifaximin for Decompensated Cirrhosis: A Hope UnfulfilledSabela Lens
Gastroenterology|November 5, 2023
Successful HCV Viral Cure Is Not the End of the StorySabela Lens
Gastroenterology|October 16, 2022
An Epidemic of Acute Hepatitis of Unknown Etiology in ChildrenSabela Lens
Gastroenterology|May 13, 2023
Bulevirtide for Chronic Hepatitis DeltaSabela Lens
Gastroenterology|June 27, 2024
Resmetirom for Non-alcoholic SteatohepatitisSabela Lens
Gastroenterology|February 22, 2024
In Search of the Best Second-Line Therapy for Primary Biliary CholangitisSabela Lens
Gastroenterology|July 25, 2025
Semaglutide in MASH: A Promising Step Forward With Room for ImprovementSabela Lens
The Lancet. Gastroenterology & Hepatology|July 13, 2023
More is not always better for novel hepatitis B therapiesSabela Lens, Xavier Forns
Atencion Primaria|October 5, 2015
[Cost-efficacy of new antiviral treatments for chronic hepatitis C]Sabela Lens, Martín Bonacci
Pageof 17